The landscape of obesity and type 2 diabetes (T2D) management is rapidly evolving with the growing use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and other pharmacologic weight-loss agents. Recent data show that 12% of U.S. adults have used a GLP-1 medication at some point. Over the past five years, GLP-1 use among patients with diabet
9150 Reached29 Comments
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7717 Reached93 Comments19 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes